Royal Bank of Canada’s Spero Therapeutics SPRO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17K | Buy |
+5,739
| New | +$17K | ﹤0.01% | 5943 |
|
|
2024
Q3 | – | Sell |
-1,959
| Closed | -$3K | – | 6870 |
|
|
2024
Q2 | $3K | Buy |
+1,959
| New | +$3K | ﹤0.01% | 6280 |
|
|
2024
Q1 | – | Sell |
-315
| Closed | – | – | 6945 |
|
|
2023
Q4 | $0 | Buy |
315
+15
| +5% | – | ﹤0.01% | 6926 |
|
|
2023
Q3 | $0 | Buy |
+300
| New | – | ﹤0.01% | 6966 |
|
|
2022
Q4 | – | Sell |
-43
| Closed | – | – | 7126 |
|
|
2022
Q3 | $0 | Buy |
+43
| New | – | ﹤0.01% | 7260 |
|
|
2022
Q2 | – | Sell |
-196,097
| Closed | -$1.71M | – | 7120 |
|
|
2022
Q1 | $1.71M | Buy |
196,097
+13,502
| +7% | +$117K | ﹤0.01% | 2800 |
|
|
2021
Q4 | $2.92M | Buy |
182,595
+2,493
| +1% | +$39.9K | ﹤0.01% | 2428 |
|
|
2021
Q3 | $3.32M | Buy |
180,102
+177,945
| +8,250% | +$3.28M | ﹤0.01% | 2286 |
|
|
2021
Q2 | $30K | Buy |
2,157
+96
| +5% | +$1.34K | ﹤0.01% | 5846 |
|
|
2021
Q1 | $30K | Buy |
2,061
+924
| +81% | +$13.5K | ﹤0.01% | 5701 |
|
|
2020
Q4 | $22K | Buy |
1,137
+510
| +81% | +$9.87K | ﹤0.01% | 5470 |
|
|
2020
Q3 | $7K | Buy |
627
+98
| +19% | +$1.09K | ﹤0.01% | 5557 |
|
|
2020
Q2 | $7K | Sell |
529
-49
| -8% | -$648 | ﹤0.01% | 5479 |
|
|
2020
Q1 | $5K | Sell |
578
-618
| -52% | -$5.35K | ﹤0.01% | 5546 |
|
|
2019
Q4 | $12K | Buy |
1,196
+896
| +299% | +$8.99K | ﹤0.01% | 5476 |
|
|
2019
Q3 | $3K | Buy |
300
+100
| +50% | +$1K | ﹤0.01% | 5559 |
|
|
2019
Q2 | $2K | Hold |
200
| – | – | ﹤0.01% | 5640 |
|
|
2019
Q1 | $3K | Buy |
200
+184
| +1,150% | +$2.76K | ﹤0.01% | 5447 |
|
|
2018
Q4 | $0 | Sell |
16
-122
| -88% | – | ﹤0.01% | 6090 |
|
|
2018
Q3 | $1K | Buy |
138
+33
| +31% | +$239 | ﹤0.01% | 6008 |
|
|
2018
Q2 | $2K | Buy |
105
+103
| +5,150% | +$1.96K | ﹤0.01% | 5683 |
|
|
2018
Q1 | $0 | Sell |
2
-64
| -97% | – | ﹤0.01% | 5949 |
|
|
2017
Q4 | $1K | Buy |
+66
| New | +$1K | ﹤0.01% | 5658 |
|